AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23611172 — intervention group
Group type: COMPARATOR
Intervention: Comparison between 5mg and 2.5mg continuation groups
Number of subjects: 78
Study 23611172 — intervention group
Group type: COMPARATOR
Intervention: 5mg group vs 2.5mg continuation group
Number of subjects: 78
Study 21369370 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsalva maneuver (Group III); blew into sphygmomanometer tubing and hold the mercury column up to 30 mm Hg for at least 20s
Number of subjects: 90
Study 21369370 — intervention group
Group type: COMPARATOR
Intervention: Control (Group I)
Number of subjects: 90
Study 21369370 — intervention group
Group type: EXPERIMENTAL
Intervention: Ball (Group II); pressed a rubber ball (attention‐diverting method)
Number of subjects: 90
Study 21369370 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 90
Study 19470677 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymoglobulin
Number of subjects: 227
Study 19470677 — intervention group
Group type: COMPARATOR
Intervention: Daclizumab
Number of subjects: 227
Study 17083009 — intervention group
Group type: EXPERIMENTAL
Intervention: MenCV (serogroup C meningococcal glycoconjugate vaccine)
Number of subjects: 274
Study 17083009 — intervention group
Group type: EXPERIMENTAL
Intervention: MenCV
Number of subjects: 274
Study 17083009 — intervention group
Group type: COMPARATOR
Intervention: MenPS (meningococcal AC plain polysaccharide vaccine)
Number of subjects: 274
Study 14733856 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampicine (R) + Pirazinamide (Z) for 2 months
Number of subjects: 172
Study 14733856 — intervention group
Group type: COMPARATOR
Intervention: Isoniazid (H) for 6 months
Number of subjects: 172
Study 11317704 — intervention group
Group type: COMPARATOR
Intervention: Normal pressure (100 kPa)
Number of subjects: 23
Study 11317704 — intervention group
Group type: EXPERIMENTAL
Intervention: Raised ambient pressure (400 kPa)
Number of subjects: 23
Study 9125680 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylcholine (0.15, 0.45, 1.5, 4.5, and 15 microg/100 ml forearm tissue/min)
Number of subjects: 17
Study 9125680 — intervention group
Group type: COMPARATOR
Intervention: Sodium nitroprusside (1, 2, and 4 microg/100 ml forearm tissue/min)
Number of subjects: 17
Study 7648143 — intervention group
Group type: EXPERIMENTAL
Intervention: Daflon 500 mg for 1 week after operation (group 1)
Number of subjects: 228
Study 7648143 — intervention group
Group type: COMPARATOR
Intervention: Control group (group 2)
Number of subjects: 228
Study 2744313 — intervention group
Group type: EXPERIMENTAL
Intervention: Gallopamil 25 mg tid
Number of subjects: 20
Study 2744313 — intervention group
Group type: EXPERIMENTAL
Intervention: Gallopamil 50 mg tid
Number of subjects: 20
Study 2744313 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 820813 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe malnutrition
Number of subjects: 97
Study 820813 — intervention group
Group type: COMPARATOR
Intervention: Antibiotic usage
Number of subjects: 97
Study 820813 — intervention group
Group type: COMPARATOR
Intervention: Presence of intestinal parasites
Number of subjects: 97
Study 820813 — intervention group
Group type: COMPARATOR
Intervention: Refeeding diet
Number of subjects: 97
Study 31374140 — intervention group
Group type: EXPERIMENTAL
Intervention: LMIC authors
Number of subjects: 279
Study 31374140 — intervention group
Group type: EXPERIMENTAL
Intervention: HIC authors
Number of subjects: 279
Study 31374140 — intervention group
Group type: EXPERIMENTAL
Intervention: Respondents
Number of subjects: 279
Study 25278342 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-control strength training (maximal endurance contractions of spring handgrip trainers, twice daily)
Number of subjects: 41
Study 25278342 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control group (trial-matched cognitive task)
Number of subjects: 41
Study 25278342 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control group (time-matched cognitive task)
Number of subjects: 41
Study 23298651 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline (1mg twice per day)
Number of subjects: 40
Study 23298651 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 20851591 — intervention group
Group type: EXPERIMENTAL
Intervention: Helium-oxygen
Number of subjects: 10
Study 18838742 — intervention group
Group type: EXPERIMENTAL
Intervention: Persisting high burden group
Number of subjects: 33
Study 18838742 — intervention group
Group type: COMPARATOR
Intervention: Caregivers without persisting high burden
Number of subjects: 33
Study 17072792 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral STN stimulation
Number of subjects: 34
Study 17072792 — intervention group
Group type: COMPARATOR
Intervention: Unilateral pallidotomy
Number of subjects: 34
Study 12971556 — intervention group
Group type: EXPERIMENTAL
Intervention: DNP (dihydroartemisinin-napthoquine-trimethoprim), one tablet twice a day for one day
Number of subjects: 130
Study 12971556 — intervention group
Group type: COMPARATOR
Intervention: Coartem/Riamet (artemether-lumefantrine), four tablets twice a day for 3 days
Number of subjects: 130
Study 10864055 — intervention group
Group type: EXPERIMENTAL
Intervention: ABCD (amphotericin B colloidal dispersion)
Number of subjects: 49
Study 10864055 — intervention group
Group type: COMPARATOR
Intervention: Amphotericin B
Number of subjects: 49
Study 10864055 — intervention group
Group type: EXPERIMENTAL
Intervention: ABCD (in open-label studies)
Number of subjects: 49
Study 8971295 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine 5 mg/week
Number of subjects: 65
Study 8971295 — intervention group
Group type: COMPARATOR
Intervention: No specific treatment (Control)
Number of subjects: 65
Study 1297643 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg granular ibuprofen
Number of subjects: 0
Study 1297643 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6395810 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice daily sustained release theophylline
Number of subjects: 0
Study 6395810 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31783739 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA-rich fish oil supplement
Number of subjects: 126
Study 31783739 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA-rich fish oil supplement
Number of subjects: 126
Study 31783739 — intervention group
Group type: COMPARATOR
Intervention: Soy oil placebo
Number of subjects: 126
Study 31783739 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal serum DHA fraction
Number of subjects: 126
Study 31783739 — intervention group
Group type: EXPERIMENTAL
Intervention: Cord blood DHA fraction
Number of subjects: 126
Study 31783739 — intervention group
Group type: EXPERIMENTAL
Intervention: Early pregnancy BMI
Number of subjects: 126
Study 31783739 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnancy weight gain
Number of subjects: 126
Study 31783739 — intervention group
Group type: EXPERIMENTAL
Intervention: ALR
Number of subjects: 126
Study 28372514 — intervention group
Group type: EXPERIMENTAL
Intervention: Surveyed group (received pre-screening lifestyle questionnaire)
Number of subjects: 10375
Study 28372514 — intervention group
Group type: COMPARATOR
Intervention: Not surveyed group (no pre-screening lifestyle questionnaire)
Number of subjects: 10375
Study 25185016 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-cuff self-locating catheters (SLCs)
Number of subjects: 78
Study 25185016 — intervention group
Group type: COMPARATOR
Intervention: Single-cuff straight Tenckhoff catheter (TC)
Number of subjects: 78
Study 24590325 — intervention group
Group type: EXPERIMENTAL
Intervention: Distally based perforator-plus sural fasciocutaneous flap in pediatric group
Number of subjects: 201
Study 24590325 — intervention group
Group type: COMPARATOR
Intervention: Distally based perforator-plus sural fasciocutaneous flap in adult group
Number of subjects: 201
Study 22273718 — intervention group
Group type: EXPERIMENTAL
Intervention: Wilms tumor 1 peptide vaccine plus gemcitabine and cisplatin (GC)
Number of subjects: 100
Study 22273718 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine and cisplatin (GC)
Number of subjects: 100
Study 19395583 — intervention group
Group type: EXPERIMENTAL
Intervention: Dichloroacetate (DCA) infusion (50 mg/kg body mass)
Number of subjects: 13
Study 19395583 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline solution)
Number of subjects: 13
Study 17466725 — intervention group
Group type: EXPERIMENTAL
Intervention: Back Rx program (15 minutes a day, 3 times a week)
Number of subjects: 50
Study 17466725 — intervention group
Group type: COMPARATOR
Intervention: Medications and cryobrace alone (Control group)
Number of subjects: 50
Study 15951880 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise training
Number of subjects: 22
Study 15951880 — intervention group
Group type: COMPARATOR
Intervention: Home-based exercise training
Number of subjects: 22
Study 12704885 — intervention group
Group type: EXPERIMENTAL
Intervention: Jejunum pouch
Number of subjects: 0
Study 12704885 — intervention group
Group type: COMPARATOR
Intervention: Simple Roux-en-Y limb
Number of subjects: 0
Study 9433873 — intervention group
Group type: EXPERIMENTAL
Intervention: Avocado/Soybean Unsaponifiables (ASU)
Number of subjects: 164
Study 9433873 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 164
Study 7661424 — intervention group
Group type: EXPERIMENTAL
Intervention: Trinder spot test performed by emergency physicians
Number of subjects: 12
Study 7661424 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum quantitative assays
Number of subjects: 12
Study 2388876 — intervention group
Group type: EXPERIMENTAL
Intervention: Home therapeutic drug-monitoring (TDM) method for theophylline blood levels
Number of subjects: 0
Study 2388876 — intervention group
Group type: COMPARATOR
Intervention: Traditional TDM method (controls)
Number of subjects: 0
Study 2388876 — intervention group
Group type: EXPERIMENTAL
Intervention: Home TDM
Number of subjects: 0
Study 26520 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadolol (100 mg once daily)
Number of subjects: 24
Study 26520 — intervention group
Group type: COMPARATOR
Intervention: Propranolol (112 mg 4-times daily)
Number of subjects: 24
Study 31566937 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabazitaxel (25 mg/m² IV every 3 weeks, plus prednisone daily and granulocyte colony-stimulating factor)
Number of subjects: 255
Study 31566937 — intervention group
Group type: COMPARATOR
Intervention: Androgen-signaling-targeted inhibitor (1000 mg of abiraterone plus prednisone daily or 160 mg of enzalutamide daily)
Number of subjects: 255
Study 31566937 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabazitaxel
Number of subjects: 255
Study 31566937 — intervention group
Group type: COMPARATOR
Intervention: Androgen-signaling-targeted inhibitor
Number of subjects: 255
Study 27847247 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium alginate initiated concomitantly with CRT (group A)
Number of subjects: 200
Study 27847247 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium alginate initiated soon after the development of extremely mild esophagitis during CRT (group B)
Number of subjects: 200
Study 27847247 — intervention group
Group type: COMPARATOR
Intervention: Water administered throughout CRT (group C)
Number of subjects: 200
Study 25881694 — intervention group
Group type: EXPERIMENTAL
Intervention: Core stabilization exercises
Number of subjects: 28
Study 23965236 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote monitoring (RM) with remote follow‐up and wireless automatic alerts
Number of subjects: 154
Study 23965236 — intervention group
Group type: COMPARATOR
Intervention: Control group with standard follow‐up without alerts
Number of subjects: 154
Study 23965236 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote monitoring (RM)
Number of subjects: 154
Study 23965236 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 154
Study 23965236 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote monitoring (RM) and Control group
Number of subjects: 154
Study 22299554 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh Frozen Plasma (FFP)
Number of subjects: 56
Study 22299554 — intervention group
Group type: COMPARATOR
Intervention: Control (routine treatment with atropine and pralidoxime)
Number of subjects: 56
Study 19216850 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (TCM) therapy for clearing heat and resolving phlegm combined with routine Western medicine.
Number of subjects: 100
Study 19216850 — intervention group
Group type: COMPARATOR
Intervention: Routine Western medicine only (control group).
Number of subjects: 100
Study 17110256 — intervention group
Group type: EXPERIMENTAL
Intervention: Twin-block appliance
Number of subjects: 55
Study 17110256 — intervention group
Group type: EXPERIMENTAL
Intervention: Bionator appliance
Number of subjects: 55
Study 17110256 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 55
Study 15577269 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacists provided regular instructions on Nicorette use and smoking cessation advice at the first sale and follow-up advice at 1, 3, 8 weeks and 3 months thereafter (Intervention group A)
Number of subjects: 28
Study 15577269 — intervention group
Group type: COMPARATOR
Intervention: Regular instructions alone (Control group B)
Number of subjects: 28
Study 15577269 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacists provided regular instructions on Nicorette use and smoking cessation advice (Intervention group A)
Number of subjects: 28
Study 11740214 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-Fluorouracil
Number of subjects: 36
Study 11740214 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 9006561 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast-conserving surgery (BCS) in British Columbia
Number of subjects: 1880
Study 9006561 — intervention group
Group type: COMPARATOR
Intervention: Breast-conserving surgery (BCS) in Ontario
Number of subjects: 1880
Study 9006561 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy after BCS in British Columbia
Number of subjects: 1880
Study 9006561 — intervention group
Group type: COMPARATOR
Intervention: Radiation therapy after BCS in Ontario
Number of subjects: 1880
Study 8255111 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuro-reflexotherapic intervention
Number of subjects: 91
Study 8255111 — intervention group
Group type: COMPARATOR
Intervention: Control group (inappropriate zones stimulated)
Number of subjects: 91
Study 3105748 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroxine (150 micrograms daily)
Number of subjects: 110
Study 3105748 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 110
Study 29785103 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese version of the Severe Respiratory Insufficiency Questionnaire (SRI)
Number of subjects: 161
Study 27607036 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% Potentilla officinalis (PO) cream
Number of subjects: 64
Study 27607036 — intervention group
Group type: COMPARATOR
Intervention: 1% hydrocortisone acetate cream
Number of subjects: 64
Study 24652604 — intervention group
Group type: EXPERIMENTAL
Intervention: TJ-14
Number of subjects: 91
Study 24652604 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study 22336189 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiosphere-derived cells (CDCs) infused into the infarct-related artery 1.5-3 months after myocardial infarction.
Number of subjects: 31
Study 22336189 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group).
Number of subjects: 31
Study 22336189 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiosphere-derived cells (CDCs) compared to standard care at 6 months.
Number of subjects: 31
Study 20517672 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin (150-300 mg daily for three weeks)
Number of subjects: 29
Study 20517672 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 20517672 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 29
Study 18721243 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 21‐P (Dex 21‐P) encapsulated into erythrocytes (DEE), 9.9 +/- 4.1 mg per infusion, two infusions 14 days apart (group A)
Number of subjects: 40
Study 18721243 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral prednisolone (0.5 mg/kg for 14 days followed by a 6 mg/weekly tapering, group B)
Number of subjects: 40
Study 18721243 — intervention group
Group type: COMPARATOR
Intervention: Sham infusions (group C)
Number of subjects: 40
Study 16358106 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic fitness program (ergometer cycle sessions 3 times a week for six months at VT‐1 intensity)
Number of subjects: 46
Study 16358106 — intervention group
Group type: COMPARATOR
Intervention: Control group (no changes in activities or exercise program)
Number of subjects: 46
Study 12472985 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol 20 mg/day plus Diazoxide 200 mg/day
Number of subjects: 42
Study 12472985 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol 20 mg/day plus Placebo
Number of subjects: 42
Study 10343133 — intervention group
Group type: EXPERIMENTAL
Intervention: La1 supernatant with omeprazole 20 mg four times a day
Number of subjects: 20
Study 10343133 — intervention group
Group type: COMPARATOR
Intervention: La1 supernatant with placebo
Number of subjects: 20
Study 8881868 — intervention group
Group type: EXPERIMENTAL
Intervention: dopexamine hydrochloride
Number of subjects: 23
Study 8881868 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 23
Study 2028084 — intervention group
Group type: EXPERIMENTAL
Intervention: Blocked trials
Number of subjects: 16
Study 2028084 — intervention group
Group type: EXPERIMENTAL
Intervention: Random trials
Number of subjects: 16
Study 7438683 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol 0.7 gm/kg orally over 15 min followed by diazepam 10 mg intravenously over 20 min and ethanol 0.15 gm/kg/hr for 8 hr
Number of subjects: 6
Study 7438683 — intervention group
Group type: COMPARATOR
Intervention: Diazepam 10 mg intravenously over 20 min
Number of subjects: 6
Study 31132798 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum visfatin levels during follow-up (2013)
Number of subjects: 2429
Study 31132798 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index (BMI) during follow-up (2013)
Number of subjects: 2429
Study 31132798 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist-to-hip ratio during follow-up (2013)
Number of subjects: 2429
Study 31132798 — intervention group
Group type: EXPERIMENTAL
Intervention: Triglycerides (TG) during follow-up (2013)
Number of subjects: 2429
Study 31132798 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-density lipoprotein (LDL) during follow-up (2013)
Number of subjects: 2429
Study 31132798 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeostasis model assessment during follow-up (2013)
Number of subjects: 2429
Study 31132798 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of diabetes during follow-up (2013)
Number of subjects: 2429
Study 31132798 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of serum visfatin with BMI
Number of subjects: 2429
Study 31132798 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of serum visfatin with presence of diabetes
Number of subjects: 2429
Study 31132798 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of leucocyte numbers with serum visfatin concentration
Number of subjects: 2429
Study 28034908 — intervention group
Group type: EXPERIMENTAL
Intervention: Room Air (RA)
Number of subjects: 287
Study 28034908 — intervention group
Group type: COMPARATOR
Intervention: 100% O2
Number of subjects: 287
Study 25774062 — intervention group
Group type: EXPERIMENTAL
Intervention: Total contact insoles (TCI) made of ethylene vinyl acetate
Number of subjects: 74
Study 25774062 — intervention group
Group type: COMPARATOR
Intervention: Flat insole (control group)
Number of subjects: 74
Study 23817868 — intervention group
Group type: EXPERIMENTAL
Intervention: Portable vocal amplifier for 3 months
Number of subjects: 40
Study 23817868 — intervention group
Group type: COMPARATOR
Intervention: Course only (no amplifier)
Number of subjects: 40
Study 21069377 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed antioxidant supplementation (vitamin C & E)
Number of subjects: 38
Study 21069377 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 19767093 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed (500 mg/m2, day 1) plus best supportive care (n=441)
Number of subjects: 663
Study 19767093 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus best supportive care (n=222)
Number of subjects: 663
Study 17445781 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetyl cysteine (NAC)
Number of subjects: 27
Study 17445781 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 15370494 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg/kg)
Number of subjects: 11
Study 15370494 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 11331168 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125% bupivacaine with fentanyl (2 micro g.ml(‐1))
Number of subjects: 226
Study 11331168 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125% bupivacaine with sufentanil (0.25 micro g.ml(‐1))
Number of subjects: 226
Study 9288222 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxymetazoline
Number of subjects: 97
Study 9288222 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study 8198902 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-tracheal adrenaline (up to 10 micrograms kg‐1)
Number of subjects: 16
Study 8198902 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous adrenaline (0.1 microgram kg‐1)
Number of subjects: 16
Study 8198902 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-tracheal doses recommended for resuscitation (2-3 mg)
Number of subjects: 16
Study 3131068 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse oximetry and capnometry monitoring
Number of subjects: 40
Study 3131068 — intervention group
Group type: EXPERIMENTAL
Intervention: Capnometry monitoring
Number of subjects: 40
Study 3131068 — intervention group
Group type: COMPARATOR
Intervention: Control group monitored with periodic ABG sampling
Number of subjects: 40